)
Edge17 Oct 2025
A Castle in the Sky: The Story of Oracle
Oracle's journey from database innovator to disciplined enterprise backbone, now shaping the AI buildout with a standardized cloud infrastructure.
WuXi Biologics (2269) investor relations material
WuXi Biologics H1 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H1 2025 earnings summary20 Aug, 2025
Executive summary
Revenue rose 16.1% year-over-year to RMB9,953.2 million for the first half of 2025, driven by expanded service offerings, global client growth, and robust demand, with a record 86 new integrated projects added.
Net profit surged 54.8% year-over-year to RMB2,756.6 million, with net profit margin improving to 27.7%.
Gross profit margin expanded to 42.7%, reflecting operational efficiencies and cost savings.
Total backlog reached US$20.3 billion as of June 30, 2025, supporting future growth and revenue visibility.
Maintained a 100% success rate in 44 regulatory inspections and high employee retention at 98.8%.
Financial highlights
Adjusted net profit rose 11.6% year-over-year to RMB2,840.0 million; adjusted net profit margin was 28.5%.
Adjusted EBITDA increased to RMB4,305.2 million, with margin at 43.3%.
Basic earnings per share grew 56.8% to RMB0.58; diluted EPS up 57.1% to RMB0.55.
Bank balances and cash rose 13.8% to RMB11,596.9 million.
Gearing ratio decreased to 5.6% from 5.8% at year-end 2024.
Outlook and guidance
Raised full-year 2025 revenue growth target to 14–16%, with improved profitability and significant free cash flow expected.
Anticipates sustained demand for integrated outsourcing services and robust biopharmaceutical sector growth.
Focus remains on enhancing platform integration, capacity optimization, and operational excellence.
No interim dividend declared for the period.
Expects IP-driven revenue to reach up to 15% of total revenue in 5–6 years, contributing 25% of profit.
How did WBS impact cost savings?
Elaborate on geographic footprint strategy.
Explain the increase in financial assets at FVTPL.
IP-driven revenue: long-term contribution?
WuXiHigh 2.0: Market expansion and revenue impact?
CapEx deferral: What's the strategic rationale?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next WuXi Biologics earnings date
H2 202525 Mar, 2026
Next WuXi Biologics earnings date
H2 202525 Mar, 2026
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Company Research17 Oct 2025
Beneath the Surface: A Conversation with Epiroc CEO Helena Hedblom
Legacy, innovation, and leading one of Sweden's most influential industrial companies into a new era.
)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
Frequently asked questions
WuXi Biologics (Cayman) Inc. is a global contract research, development, and manufacturing organization (CRDMO) focused on biologics. The company offers comprehensive services that span from biologic discovery and development to commercial manufacturing. Key offerings include protein generation, antibody development, assay development, and regulatory affairs. The company is headquartered in Wuxi, China, and its shares are listed on the Hong Kong Stock Exchange.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage